UNSPSC 51161556: Tomelukast

This classification denotes an anti-asthmatic agent with the molecular formula C16H22N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 59762X5CLS, chemically known as ly-171,883 but generally known as tomelukast, which bears US NIH Compound Identifier 3969. European Medicines Agency schedules Tomelukast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11184MIG. The term TOMELUKAST is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29).

UNSPSC 51161556 Tomelukast, a Commodity code, identifies a specific pharmaceutical product — tomelukast, a leukotriene receptor antagonist used in asthma and allergy treatment — that state and local health agencies procure for public health programs, safety-net clinics, emergency departments, and inpatient formularies. State and local purchasing offices, Medicaid agencies, public health departments, hospital systems, and school health services source this medication through competitive bidding, group purchasing organizations, and state pharmaceutical contract vehicles. The code's narrow scope reflects procurement of a single active pharmaceutical ingredient rather than a broad therapeutic class or medication family.

The source provided contains no recent state and local contract opportunities posted under UNSPSC 51161556. Without posted solicitations or awarded contracts, geographic concentration and issuing-body patterns cannot be characterized from current market activity.